🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study intends to evaluate the following objectives in patients with adv...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-13
Trial ID
NCT02992340
Treatments Being Tested
The purpose of this study is to determine whether ASLAN001 has an effect in...
Status
Completed
Location
Seoul National University Hospital
Start Date
2012-03
Trial ID
NCT01614522
Treatments Being Tested
This is an open-label, randomized, parallel group Phase 2A/2B study to eval...
Status
Completed
Location
Australia
Start Date
2014-12-29
Trial ID
NCT02338245
Treatments Being Tested
This study is designed to study the efficacy of ASLAN 001 plus capecitabine...
Status
Terminated
Location
National Cancer Centre Singapore
Start Date
2016-08-11
Trial ID
NCT07166367
Treatments Being Tested
This is a Phase I, open-label, dose escalation study of ASLAN001 given in c...
Status
Unknown
Location
National Cancer Centre
Start Date
2014-08
Trial ID
NCT02435927
Treatments Being Tested
The current standard of care for stage I-III HER2-positive breast cancer is...
Status
Unknown
Location
National University Hospital
Start Date
2015-03
Trial ID
NCT02396108
Treatments Being Tested
The purpose of this study is to explore safety and efficacy of varlitinib a...
Status
Completed
Location
ASLAN Selected sites
Start Date
2017-01-31
Trial ID
NCT03082053
Treatments Being Tested
This protocol for Varlitinib is developed for the treatment of Biliary Trac...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2017-07-04
Trial ID
NCT03093870
Treatments Being Tested
This is a phase IB study to assess the safety and tolerability of ASLAN001 ...
Status
Completed
Location
Queen Mary Hospital
Start Date
2014-08-05
Trial ID
NCT02648425
Treatments Being Tested
This protocol for Varlitinib is developed for the treatment of Gastric Canc...
Status
Completed
Location
2 Sites
Start Date
2017-08-31
Trial ID
NCT03130790
Treatments Being Tested